Skip to main content
Fig. 5 | Radiation Oncology

Fig. 5

From: Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study

Fig. 5

Tolerability of contrast medium application and irradiation. a Premature spot baldness in the irradiation field. b Serum alanine aminotransferase activities in naïve animals, control animals (only contrast-enhanced CT scans), and radiotherapy-treated animals (contrast-enhanced CT scans plus irradiation) after 2 weeks of therapy (d18). p-values were calculated by Student’s t-test with Bonferroni-Holm correction. c Corresponding histological analyses of exemplary 10 μm sections of livers and kidneys (H&E staining, light microscopy at 10x and 40x magnification). Scale bars as indicated

Back to article page